A Randomised Controlled Trial Of Interventional Versus Conservative Treatment Of Primary Spontaneous Pneumothorax
Funder
National Health and Medical Research Council
Funding Amount
$412,315.00
Summary
Primary spontaneous pneumothorax (PSP) is a collapsed lung that occurs in otherwise healthy people without underlying lung disease. Current standard treatment is to insert a chest drain into the chest to remove the air around the collapsed lung so that the lung re-inflates rapidly ("interventional treatment"). We will determine whether doing nothing, i.e. letting the lung re-inflate slowly on its own over several weeks ("conservative treatment"), is just as good or even better for patients.
Synchromodal container logistics for Australia. Synchromodal container logistics for Australia. This project aims to develop advanced mathematical optimization models and algorithms to create multi-modal logistics approaches for container movements in and out of Australia’s busy ports. The increasingly congested capital cities of Sydney, Brisbane and Melbourne need to find new ways of moving an increasing volume of containerized freight. Moving from trucks to rail is expected to reduce pollution ....Synchromodal container logistics for Australia. Synchromodal container logistics for Australia. This project aims to develop advanced mathematical optimization models and algorithms to create multi-modal logistics approaches for container movements in and out of Australia’s busy ports. The increasingly congested capital cities of Sydney, Brisbane and Melbourne need to find new ways of moving an increasing volume of containerized freight. Moving from trucks to rail is expected to reduce pollution and road congestion, but is only possible if highly efficient modes of operation can be developed. Research into system design and operational scheduling is expected to achieve the required efficiency for multi-modal logistics that will reduce air pollution and road congestion.Read moreRead less
Ensuring Australia's competitiveness by implementing targeted performance measurement systems across the extended supply chain. This project will develop a framework to guide managers in designing, implementing, and using performance measurement systems across the industry supply chain to maximise the potential benefits of supply chain management. The outcomes enhance organisational competitiveness, supply chain competitiveness and boost Australia's economy.
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE130100035
Funder
Australian Research Council
Funding Amount
$300,000.00
Summary
Hyperpolarised gas functional lung and molecular imaging. This project will produce a polariser to generate magnetised gas for research with magnetic resonance imaging (MRI). This allows imaging of normal and abnormal lung ventilation and circulation in animal and humans. The use of these hyperpolarised gases can also be used to tag specific molecules and increase understanding of lung metabolism.
Patterns, Pathways And Price Of Developing Disparities In Cardiovascular And Respiratory Health By Age 11-12 Years: The Longitudinal Study Of Australian Children
Funder
National Health and Medical Research Council
Funding Amount
$3,290,912.00
Summary
Cardiovascular and lower respiratory diseases are leading causes of death, show marked social gradients, and have origins in early life. We will measure cardiorespiratory health at age 11-12 years in the national Longitudinal Study of Australian Children. Combined with rich existing psychosocial and health data spanning the entire first decade, we will explore early-life mechanisms underlying emerging patterns of social disparity and their potentially-avoidable cost – evidence that is essential ....Cardiovascular and lower respiratory diseases are leading causes of death, show marked social gradients, and have origins in early life. We will measure cardiorespiratory health at age 11-12 years in the national Longitudinal Study of Australian Children. Combined with rich existing psychosocial and health data spanning the entire first decade, we will explore early-life mechanisms underlying emerging patterns of social disparity and their potentially-avoidable cost – evidence that is essential to develop new intervention strategies.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0237908
Funder
Australian Research Council
Funding Amount
$637,000.00
Summary
Mass Spectrometry Instrumentation for Therapeutic Lead Discovery. Drug discovery is reliant on the application of basic research and advanced technologies to obtain solutions to human suffering caused by diseases. This application seeks funding to support the installation of state-of-the-art mass spectrometry instrumentation at Griffith University and the University of Melbourne. The requested instrumentation will enhance high quality collaborative research programs in drug discovery and eradica ....Mass Spectrometry Instrumentation for Therapeutic Lead Discovery. Drug discovery is reliant on the application of basic research and advanced technologies to obtain solutions to human suffering caused by diseases. This application seeks funding to support the installation of state-of-the-art mass spectrometry instrumentation at Griffith University and the University of Melbourne. The requested instrumentation will enhance high quality collaborative research programs in drug discovery and eradicate significant deficiencies in research infrastructure at both institutions. Access to state-of-the-art mass spectrometry instrumentation will markedly improve our international competitiveness across a broad range of biological and chemical science disciplines.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE120100025
Funder
Australian Research Council
Funding Amount
$380,000.00
Summary
A high-throughput screening and sequencing facility for single cell genomics. Genomics has revolutionised biology, but for most microorganisms this revolution has not arrived because very few can be grown in pure culture. The single cell genomics facility will address this major bottleneck by allowing as little as a single cell in a clinical or environmental setting to be sequenced thereby accelerating new discoveries and outcomes.